We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
-13.42%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$390B
AUM Growth
-$94.7B
Cap. Flow
+$10.4B
Cap. Flow %
2.66%
Top 10 Hldgs %
28.21%
Holding
14,957
New
1,520
Increased
5,503
Reduced
5,522
Closed
2,191

Sector Composition

Rank Sector Weight
1 Healthcare 2.83%
2 Technology 2.79%
3 Financials 2.29%
4 Consumer Discretionary 1.93%
5 Industrials 1.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MILE
12051
PUT
DELISTED
Metromile, Inc. Common Stock
MILE
$35K ﹤0.01%
37,700
-900
-2% -$919
PTE
12052
DELISTED
PolarityTE, Inc. Common Stock
PTE
$35K ﹤0.01%
23,792
+13,021
+121% +$47.1K
CRNT icon
12053
PUT
Ceragon Networks
CRNT
$200M
$34K ﹤0.01%
13,200
-75,200
-85% -$143K
DLNG icon
12054
CALL
Dynagas LNG Partners
DLNG
$140M
$34K ﹤0.01%
+10,200
New +$36.8K
SEGG
12055
Sports Entertainment Gaming Global Corp
SEGG
$8.21M
$34K ﹤0.01%
22
+13
+144% +$33.9K
RCAT icon
12056
PUT
Red Cat Holdings
RCAT
$1.7B
$34K ﹤0.01%
16,500
-30,200
-65% -$60K
TOUR
12057
Tuniu
TOUR
$53.2M
$34K ﹤0.01%
3,203
+816
+34% +$5.14K
WKSP icon
12058
CALL
Worksport
WKSP
$10.7M
$34K ﹤0.01%
+1,750
New +$39.7K
TLIS
12059
DELISTED
Talis Biomedical Corporation Common Stock
TLIS
$34K ﹤0.01%
+2,816
New +$44.5K
LTCH
12060
CALL
DELISTED
Latch, Inc. Common Stock
LTCH
$34K ﹤0.01%
29,700
-32,500
-52% -$83.1K
EAR
12061
PUT
DELISTED
Eargo, Inc. Common Stock
EAR
$34K ﹤0.01%
2,280
-695
-23% -$32.8K
SLHG
12062
DELISTED
Skylight Health Group Inc Common Shares
SLHG
$34K ﹤0.01%
+70,431
New +$55K
CO
12063
PUT
DELISTED
Global Cord Blood Corporation
CO
$34K ﹤0.01%
11,600
-4,200
-27% -$13K
MTL
12064
DELISTED
Mechel PAO American Depository Shares, each representing two ordinary shares (ADSs)
MTL
$34K ﹤0.01%
41,153
+500
+1% +$413
AQMS icon
12065
Aqua Metals
AQMS
$9.99M
$33K ﹤0.01%
205
+31
+18% +$6.08K
AQST icon
12066
CALL
Aquestive Therapeutics
AQST
$533M
$33K ﹤0.01%
51,300
+37,300
+266% +$49.6K
BRFS
12067
PUT
DELISTED
BRF SA
BRFS
$33K ﹤0.01%
12,800
-2,900
-18% -$8.56K
ORIO
12068
PUT
Orion Digital Corp
ORIO
$20.1M
$33K ﹤0.01%
12,967
-5,566
-30% -$26.5K
PPBT
12069
CALL
Purple Biotech
PPBT
$2.44M
$33K ﹤0.01%
69
-66
-49% -$39.5K
REED
12070
DELISTED
Reeds, Inc. Common Stock
REED
$33K ﹤0.01%
4,139
+3,887
+1,542% +$42.5K
IVC
12071
CALL
DELISTED
Invacare Corporation
IVC
$33K ﹤0.01%
+25,400
New +$33.5K
ASAP
12072
CALL
DELISTED
Waitr Holdings Inc. Common Stock
ASAP
$33K ﹤0.01%
10,805
-1,970
-15% -$8.71K
QNGY
12073
CALL
DELISTED
Quanergy Systems, Inc.
QNGY
$33K ﹤0.01%
3,970
+335
+9% +$7.53K
XELA
12074
CALL
DELISTED
Exela Technologies, Inc. Common Stock
XELA
$33K ﹤0.01%
72
+22
+44% +$23.9K
NBRV
12075
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
$33K ﹤0.01%
7,152
+6,649
+1,322% +$43.4K

Similar funds

Ken Griffin's Q2 2022 Portfolio in Review

As of Q2 2022, Ken Griffin held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Ken Griffin's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.

By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.

  • Ken Griffin's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
  • Ken Griffin added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
  • Ken Griffin's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
  • Ken Griffin fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
  • Ken Griffin's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
  • Ken Griffin opened 1,520 new positions and closed 2,191 in Q2 2022.
  • Ken Griffin's portfolio value fell 20% quarter-over-quarter to $390B.

Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.